Eli Lilly Co Drug Patent Portfolio
Eli Lilly Co owns 1 orange book drug protected by 6 US patents Given below is the list of Eli Lilly Co's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6821975 | Beta-carboline drug products | 19 May, 2021 | Expired |
| US6821975 | Beta-carboline drug products | 19 Nov, 2020 | Expired |
| US7182958 | β-carboline pharmaceutical compositions | 26 Oct, 2020 | Expired |
| US7182958 | β-carboline pharmaceutical compositions | 26 Apr, 2020 | Expired |
| US5859006 | Tetracyclic derivatives; process of preparation and use | 21 May, 2018 | Expired |
| US5859006 | Tetracyclic derivatives; process of preparation and use | 21 Nov, 2017 | Expired |
Latest Legal Activities on Eli Lilly Co's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Eli Lilly Co.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Review Certificate Mailed | 27 Jun, 2019 | US6821975 (Litigated) |
| Review Certificate Mailed | 26 Jun, 2019 | US7182958 (Litigated) |
| Review Certificate | 12 Jun, 2019 | US7182958 (Litigated) |
| Review Certificate | 12 Jun, 2019 | US6821975 (Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Jul, 2018 | US7182958 (Litigated) |
| Termination or Final Written Decision | 03 Aug, 2016 | US6821975 (Litigated) |
| Termination or Final Written Decision | 03 Aug, 2016 | US7182958 (Litigated) |
|
Request for Trial Granted
Critical
| 04 Aug, 2015 | US7182958 (Litigated) |
| Petition Requesting Trial | 13 Jan, 2015 | US7182958 (Litigated) |
| Petition Requesting Trial | 13 Jan, 2015 | US6821975 (Litigated) |
| Post Issue Communication - Certificate of Correction | 13 Nov, 2007 | US7182958 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Feb, 2007 | US7182958 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 27 Feb, 2007 | US7182958 (Litigated) |
|
Issue Notification Mailed
Critical
| 07 Feb, 2007 | US7182958 (Litigated) |
| Dispatch to FDC | 22 Jan, 2007 | US7182958 (Litigated) |
Eli Lilly Co's Drug Patent Litigations
Eli Lilly Co's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 13, 2015, against patent number US7182958. The petitioner Actelion Pharmaceuticals Ltd, challenged the validity of this patent, with ICOS Corporation as the respondent. Click below to track the latest information on how companies are challenging Eli Lilly Co's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6821975 | January, 2015 |
FWD Entered
(03 Aug, 2016)
| ICOS Corporation | Actelion Pharmaceuticals Ltd |
| US7182958 | January, 2015 |
FWD Entered
(03 Aug, 2016)
| ICOS Corporation | Actelion Pharmaceuticals Ltd |
Eli Lilly Co's Family Patents
Eli Lilly Co Drug List
Given below is the complete list of Eli Lilly Co's drugs and the patents protecting them.
1. Adcirca
Adcirca is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6821975
(Pediatric)
| Beta-carboline drug products |
19 May, 2021
(3 years ago)
| Expired |
| US6821975 | Beta-carboline drug products |
19 Nov, 2020
(4 years ago)
| Expired |
| US7182958
(Pediatric)
| β-carboline pharmaceutical compositions |
26 Oct, 2020
(4 years ago)
| Expired |
| US7182958 | β-carboline pharmaceutical compositions |
26 Apr, 2020
(4 years ago)
| Expired |
| US5859006
(Pediatric)
| Tetracyclic derivatives; process of preparation and use |
21 May, 2018
(6 years ago)
| Expired |
| US5859006 | Tetracyclic derivatives; process of preparation and use |
21 Nov, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adcirca's drug page